Skip to content

Medical-device intelligence

PLO: Meningitis/Encephalitis Pathogen Multiplex Nucleic Acid Detection System

FDA product code PLO: Meningitis/Encephalitis Pathogen Multiplex Nucleic Acid Detection System. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
PLO
FDA device name
Meningitis/Encephalitis Pathogen Multiplex Nucleic Acid Detection System
Device class
2
Regulation number
866.3970
Medical specialty
Microbiology
Review panel
MI

FDA definition

A meningitis/encephalitis pathogen multiplex nucleic acid detection system is a qualitative in vitro diagnostic test for the direct detection and identification of microbial-associated nucleic acids in cerebrospinal fluid. The test is indicated for individuals with signs and symptoms of meningitis or encephalitis and aids in diagnosis of agents of meningitis or encephalitis when used in conjunction with clinical and other laboratory findings.
Explore microbiology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

3 clearance records and 2 recall records in the covered releases, across 3 source company names and 1 product codes. Dated history runs from Mar 17, 2016 to Oct 29, 2024.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

5 matching records
Device / recordCompany in FDA recordSourceSource date
QIAstat-Dx Meningitis/Encephalitis (ME) PanelK242256 · PLOQIAGEN GmbH510(k)Oct 29, 2024FDA decision date
MOL3650 Simplexa VZV Direct - Product Usage: is intended for use on the LIAISON MDX instrument for the qualitative detection of varicella-zoster …Z-2548-2020 · PLODiaSorin Molecular LLCRecallJul 10, 2020FDA classification date
Simplexa VZV Direct, Simplexa VZV Positive Control PackK190219 · PLODiasorin Molecular, LLC510(k)May 13, 2019FDA decision date
-Outer Kit Box (P/N RFIT-LBL-0140) - FilmArray Meningitis/Encephalitis (ME) Panel REF RFIT-ASY-0118 30 For FilmArray systems LOT KIT UDI (0…Z-0446-2019 · PLOBioFire Diagnostics, LLCRecallNov 10, 2018FDA record creation date
FilmArray Meningitis/Encephalitis (ME) Panel for use with FilmArray TorchK160462 · PLOBiofire Diagnostics, LLC510(k)Mar 17, 2016FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗